CN104560894A - 编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 - Google Patents
编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 Download PDFInfo
- Publication number
- CN104560894A CN104560894A CN201310484616.6A CN201310484616A CN104560894A CN 104560894 A CN104560894 A CN 104560894A CN 201310484616 A CN201310484616 A CN 201310484616A CN 104560894 A CN104560894 A CN 104560894A
- Authority
- CN
- China
- Prior art keywords
- cell
- tumor
- recombinant virus
- cells
- hla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310484616.6A CN104560894B (zh) | 2013-10-16 | 2013-10-16 | 编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310484616.6A CN104560894B (zh) | 2013-10-16 | 2013-10-16 | 编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104560894A true CN104560894A (zh) | 2015-04-29 |
CN104560894B CN104560894B (zh) | 2017-07-14 |
Family
ID=53077974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310484616.6A Active CN104560894B (zh) | 2013-10-16 | 2013-10-16 | 编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104560894B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106349391A (zh) * | 2015-07-17 | 2017-01-25 | 中国科学院深圳先进技术研究院 | Hbv特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环dna及应用 |
CN106591371A (zh) * | 2016-11-25 | 2017-04-26 | 哈尔滨百伊生生物科技有限公司 | Cd16a/gpc3双抗慢病毒表达载体及其构建方法和应用 |
CN107164338A (zh) * | 2017-06-27 | 2017-09-15 | 镇江市卫克生物科技有限公司 | 一种重组溶瘤病毒及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101802010A (zh) * | 2007-07-10 | 2010-08-11 | 费里德瑞奇亚历山大大学 | 重组、单链、三价三特异性或双特异性抗体衍生物 |
CN101864452A (zh) * | 2009-04-16 | 2010-10-20 | 中国人民解放军军事医学科学院军事兽医研究所 | 一种双特异抗肿瘤重组腺病毒及其构建方法和应用 |
WO2013026839A1 (en) * | 2011-08-23 | 2013-02-28 | Roche Glycart Ag | Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
-
2013
- 2013-10-16 CN CN201310484616.6A patent/CN104560894B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101802010A (zh) * | 2007-07-10 | 2010-08-11 | 费里德瑞奇亚历山大大学 | 重组、单链、三价三特异性或双特异性抗体衍生物 |
CN101864452A (zh) * | 2009-04-16 | 2010-10-20 | 中国人民解放军军事医学科学院军事兽医研究所 | 一种双特异抗肿瘤重组腺病毒及其构建方法和应用 |
WO2013026839A1 (en) * | 2011-08-23 | 2013-02-28 | Roche Glycart Ag | Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
Non-Patent Citations (1)
Title |
---|
熊冬生等: "抗CD3/抗CD20双特异双链抗体的生物学活性研究", 《中华微生物学和免疫学杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106349391A (zh) * | 2015-07-17 | 2017-01-25 | 中国科学院深圳先进技术研究院 | Hbv特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环dna及应用 |
CN106591371A (zh) * | 2016-11-25 | 2017-04-26 | 哈尔滨百伊生生物科技有限公司 | Cd16a/gpc3双抗慢病毒表达载体及其构建方法和应用 |
CN107164338A (zh) * | 2017-06-27 | 2017-09-15 | 镇江市卫克生物科技有限公司 | 一种重组溶瘤病毒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104560894B (zh) | 2017-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109468282B (zh) | 一种靶向cd19的嵌合抗原受体t细胞的制备方法及应用 | |
CN110041433A (zh) | 一种靶向bcma的嵌合抗原受体及其应用 | |
CN107287164A (zh) | 靶向cd19的嵌合抗原受体t细胞、制备方法及应用 | |
CN107164338A (zh) | 一种重组溶瘤病毒及其应用 | |
CN104910279A (zh) | 靶向癌胚抗原的嵌合抗原受体、慢病毒表达载体及其制备方法和应用 | |
CN105296433A (zh) | 一种ctla4抗体、其药物组合物及其用途 | |
CN107034235A (zh) | 联合靶向pd‑1及egfr的嵌合性抗原t细胞肿瘤免疫方法 | |
CN105949325A (zh) | 包含cd27胞内结构域的嵌合抗原受体、慢病毒载体及其应用 | |
Ramachandran et al. | An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors | |
CN105017428B (zh) | 双靶向融合蛋白及其编码基因与应用 | |
CN111606999B (zh) | 兼具激活免疫共刺激信号通路和阻断免疫检查点的复制型溶瘤腺病毒及其应用 | |
CN105949323A (zh) | 一种EpCAM特异性嵌合抗原受体及其编码基因、应用 | |
CN108641000A (zh) | 肝癌的双靶点car-t治疗载体及其构建方法和应用 | |
CN105802909A (zh) | 具有her2特异性tcr的t细胞制备物及其用途 | |
CN110055269A (zh) | 人间皮素嵌合抗原受体、其t细胞及其制备方法和用途 | |
CN104560894A (zh) | 编码分泌介导效应细胞杀伤靶细胞的双特异分子的框架及病毒 | |
CN103910799B (zh) | 一种基于抗egfr单链抗体及精氨酸九聚体的融合蛋白与应用 | |
CN105367661B (zh) | 嵌合抗原受体及其基因和重组表达载体、工程化her1靶向性的nkt细胞及其应用 | |
Zhang et al. | Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8+ T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma | |
CN111732665B (zh) | 一种靶向表达癌胚抗原的细胞的嵌合抗原受体 | |
CN108864289A (zh) | 胃癌的双靶点car-t治疗载体及其构建方法和应用 | |
CN108659133A (zh) | 肺癌的双靶点car-t治疗载体及其构建方法和应用 | |
CN110144327A (zh) | 一种靶向性抗肿瘤t细胞及其制备方法和应用 | |
CN105924526B (zh) | 嵌合抗原受体及其基因和重组表达载体、carher1-nkt细胞及其制备方法和应用 | |
CN103360497A (zh) | 一种新型抗肿瘤融合蛋白疫苗及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170725 Address after: 300000 Tianjin free trade area (Airport Economic Zone) ring road 76 West Airport Business District 19 Building 201 Patentee after: TIMMUNE BIOTECH Inc. Address before: 101300 No. 9 West Fourth Ring Road, Beijing, Haidian District 2108-136 Patentee before: BEIJING ZHONGKE YONGBANG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210330 Address after: 16 / F, Beike building, 59 Gaoxin South 9th Road, Yuehai street, Nanshan District, Shenzhen, Guangdong 518000 Patentee after: SHENZHEN BEIKE BIO-TECHNOLOGY Co.,Ltd. Address before: Room 201, building 19, West District, airport business park, No.76 Huanhe North Road, Tianjin Free Trade Zone (Airport Economic Zone) Patentee before: TIMMUNE BIOTECH Inc. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150429 Assignee: Harbin Beike Health Technology Co.,Ltd. Assignor: SHENZHEN BEIKE BIO-TECHNOLOGY Co.,Ltd. Contract record no.: X2023440020002 Denomination of invention: The framework and virus of double specific molecules encoding secretory mediated effector cell killing target cells Granted publication date: 20170714 License type: Common License Record date: 20230116 |